Bronchial asthma
Conditions
Interventions
Syndrome differentiation of traditional Chinese me:maqinkechuanheji
bufeikeli
Conventional western medicine treatment group:seretide
Sponsors
The second affiliated hospital of Tianjin Medical University
Eligibility
Sex/Gender
All
Age
14 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Accord with standard of bronchial asthma diagnosis, disease in the acute phase, severity is a mild persistent (level 2) and moderate continuous (level 3); 2. re xiao dialectical standard; 3. Patients aged 14-70; 4. Informed consent and voluntary subjects and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. The merger can cause shortness of breath or breathing difficulties of other diseases such as bronchiectasis disease, chronic obstructive pulmonary disease, cystic fibrosis, lung cancer, lung tuberculosis, lung resection history, congestive heart failure, etc.); 2. Pregnancy and lactation women; 3. This experimental drug ingredients known allergies; 4. Serum creatinine (Cr), urea nitrogen (BUN) than normal ceiling, cereal third transaminase (ALT) exceeds the upper limit of normal 1.5 times; 5. Merger intentional serious primary diseases such as cerebrovascular, kidney and hematopoietic system, mental patients; 6. Taking part in other clinical researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ECP;HDAC;CySLT;LTE; | — |
Countries
China
Contacts
Public ContactSun Zengtao
The second affiliated hospital of Tianjin Medical University
Outcome results
None listed